1. ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class — Gilead, Galapagos share 52-week update on filgotinib — UPS gets clearance to expand medical drone delivery service across US — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Toxic Work Environment

Discussion in 'KCI' started by anonymous, Aug 21, 2018 at 5:42 PM.

  1. anonymous

    anonymous Guest

    I agree SNAP is trash. I don’t have to sell it either or I would slit my wrists. I feel sorry for the TSV’s. Dead end.
     
  2. anonymous

    anonymous Guest

    Did I say nobody knows about it? No, but you don’t underestand that KCI drastically underestimated how it affected sales. Keep drinking that Koolaid. And yeah, $43 million was a joke. I have a log in the toilet I could have sold them for ten bucks.
     
  3. anonymous

    anonymous Guest

    You get a gold star for internet research. You must be a millennial manager. By the way, there are plenty of articles that say “Terms of the deal were not disclosed”. My point had nothing to do with the amount paid being public or not, it has to do with it being absurd that KCI paid more than ten bucks.

    https://www.bizjournals.com/sananto...lity-acquires-wound-care-technology-from.html
     
  4. anonymous

    anonymous Guest

    Doctors laugh at SNAP. I have been selling wound care for a long time and the doctors who I know very well tell me that there are very few patients who need SNAP. Small and discreet is not that big of a deal when you are trying to heal a wound and you want to make sure that negative pressure is effective. That is the truth.
     
  5. anonymous

    anonymous Guest

    You must be old, not being able to search and read SEC 10k filings on the internet, public knowledge. Sure it’s over 100 pages but it gives a person deep insight of exactly what the company is doing with financial data, spelled out.

    You can bitch all you want on CafePharma and call me a manager, which I’m not(thanks for the compliment) but you got to sell SNAP or start looking elsewhere. Pretty much it.

    Business makes money, reps are casualties. Apex partners wants their $6billion investment back. Sure you have given it your most, made the company money, but you didn’t put in $6billion or $6 to buy KCI. You were hired as a rep. Go raise venture capital and buy KCI yo change things. Money talks, BS walks.
     
  6. anonymous

    anonymous Guest

    Go ask DG, the snap guy, how Spiacular got acquired. He can fill you in with great detail. High level execs take care of friends.
     
  7. anonymous

    anonymous Guest

    Hey, slick, do you understand that I don’t care how much they paid and I have better things to do than searching through financials from a shit ass company. The point I am making is that paying anything for a niche product with terrible reimbursement like SNAP was a mistake. But please keep focused on the fact that I don’t spend my time searching the Internet LOL. Snap is not good. Terrible reimbursement information given to us by the company, small amount of patients that actually fit the profile for who it would work for, and the studies that back up snap are terrible. You should try reading them without the Koolaid goggles on. The wounds that snap treated were much smaller than the wound VAC. Moron.
     
  8. anonymous

    anonymous Guest

    i don't disagree that SNAP is inferior. As I stated earlier, I would slit my wrists if I was a TSV mandated to sell it. Yes it is literally a junk product but overall the SNAP was a friends business deal that the Spiracular upper level Mgmt made millions in their pocket. Unfortunately now it’s in your portfolio and sales have to pay off the $43 million debt. My calculations estimate it will take 7-10 years to pay off that product purchase price. The due diligence of that product was horrible. The KCI corporate team got hood winked. I watch my TSV struggle with the sale. Unfortunately it is not going away anytime soon. So my point is, do you want to stay pushing the SNAP product with Mgmt on your back or is it time to bolt? That’s a serious question only you can decide.
     
  9. anonymous

    anonymous Guest

    Hey slickless, that’s probably why you will always be a TSV because you can’t understand corporate finances, mergers & acquisitions and the corporate world. Knowing the dynamics of a company you work for, even before you start, helps with due diligence for the future. You must have a BSN since you are so ignorant about business. If you do have a business degree, you need to get your money back from your online degree. BOOM bitch
     
  10. anonymous

    anonymous Guest

    SNAP is absolute junk. It’s demise is predictable but it’s going to cause a lot of misery and probably job loss too before they bury it. How Acelity was the least bit threatened by this product I will never understand. Appropriate for 3rd world applications only.
     
  11. anonymous

    anonymous Guest

    Ignorant about business? The first rule in business is to base future decisions on what is best for the company and not base them on what you paid for something. You must have been absent that semester in business school.
     
  12. anonymous

    anonymous Guest

    SNaP is a niche product. It gave people who did not like KCI an out. The VA was all about less paperwork and accessibility. Welcome to private equity. people do not matter TSV's are not highly thought of and the glory goes to TMV's. The TMV who states they are not a manager is an arrogant know it all. Unrealistic expectations are made because of upper management's are just talking heads beholden to APEX partners. You have to come to the realization that you are a number and when you can't produce, you will find ways to do it (Fraud - forging wound progress reports, stuffing accounts with products, selling off-label to meet quotas) or be on the street. If you complain, there is the door. A good manager can work through when a situation is the fault of the representative or that circumstances are out of a reps control. What is the volume of the territory? How big is the territory? What is the territory opportunity? How penetrated is the territory? What does competition look like? What do the reps sales calls look like? What is the reps business plan? What does the PnL look like? What are the managed care challenges?
    Great products (most of them) but there is a push just to flip a company that was supposed to be sold 3-4 years ago. Nothing more embarrassing than having to pull an IPO filing...Acelity will be bought and scooped up by some big entity and senior managers will get their big bonuses and be on their way while the field fears for their future.